(
0.6 mmol) sodium hydroxide and 35 mg (0.03 mmol)
Tris{4-[8-(2-(2,6-diisopropylphenyl)-1H-benzo[5,10]anthra-
tetrakis(triphenylphosphine)palladium(0) in 60 ml DME were
[2,1,9-def]isoquinoline-1,3(2H)-dione)]-4,39,30,3-,39-,30--
hexahexyl-2,29;59,20;50,2-;5-,29-;59-,20--sexithien-50--yl]-
phenyl}amine (9)
reacted at 80 uC for 24 hours to give 5 (110 mg, 62%) as a black
solid after column chromatography (dichloromethane : petrol
1
ether [5 : 1]): mp 247–248 uC; H NMR (CDCl
J = 8.0 Hz, 6H, Pery-1H,6H), 8.50–8.40 (m, 12H, Pery-
3
): d = 8.64 (d,
Following the general procedure, 48 mg (0.03 mmol) perylenyl-
sexithiophene 8, 6 mg (0.01 mmol) of boronic ester 3, 2.4 mg
2H,5H,7H,12H), 8.00 (d, J = 8.5 Hz, 3H, Pery-8H), 7.67 (d, J =
7.7 Hz, 3H, Pery-10H), 7.62 (t, J = 7.8 Hz, 3H, Pery-11H),
7.55 (d, J = 8.6 Hz, 6H, TPA-3H,5H), 7.48 (t, J = 7.8 Hz, 3H,
(
(
0.06 mmol) sodium hydroxide and 7 mg (6 mmol) tetrakis-
triphenylphosphine)palladium(0) in 1 ml DME were reacted
at 60 uC for 24 hours to give 9 (20 mg, 43%) as a black
solid after column chromatography (dichloromethane : petrol
Ph-4H), 7.34 (d, J = 7.8 Hz, 6H, Ph-3H,5H), 7.20–7.10 (m,
2H, TPA-2H,6H,Th-3H,49H), 2.92–2.81 (m, 6H, Ph-CH-
CH ), 2.78 (t, J = 6.8 Hz, 6H, Th-a9-CH ), 2.46 (t, J =
.5 Hz, 6H, Th-a-CH ), 1.81–1.70 (m, 6H, Th-b9-CH ), 1.64–
1
1
ether [5 : 1]): mp 145–146 uC; H NMR (CDCl ): d = 8.68 (d,
3
(
3
)
2
2
J = 7.8 Hz, 6H, Pery-1H,6H), 8.57–8.49 (m, 12H, Pery-
7
1
1
2
2
2H,5H,7H,12H), 8.01 (d, J = 8.4 Hz, 3H, Pery-8H), 7.70 (d, J =
7.8 Hz, 3H, Pery-10H), 7.65 (t, J = 8.0 Hz, 3H, Pery-11H),
7.51 (d, J = 8.7 Hz, 6H, TPA-3H,5H), 7.48 (t, J = 7.8 Hz, 3H,
.50 (m, 6H, Th-b-CH ), 1.50–1.40 (m, 6H, Th-c9-CH ),
2
2
.40–1.08 (m, 30H, -CH
2
-), 1.21 (d, J = 6.8 Hz, 36H Ph-CH-
), 0.78 (t, J = 6.9 Hz,
): d = 163.84, 146.43, 145.64,
(
CH
3
)
2
), 0.89 (t, J = 6.9 Hz, 9H, Th9-CH
3
Ph-4H), 7.34 (d, J = 7.7 Hz, 6H, Ph-3H,5H), 7.18–7.10 (m,
1
3
9
1
1
1
1
3
2
H, Th-CH
3
); C NMR (CDCl
3
1
2H, TPA-2H,6H,Th-3H,49H), 7.02 (s, 3H, Th0-4H), 7.01 (s,
H, Th-4-H), 6.98 (s, 3H, Th-49-H), 2.90–2.75 (m, 36H, Ph-
41.87, 141.41, 140.56, 137.39, 137.12, 136.20, 134.85, 133.81,
33.72, 131.92, 130.99, 130.39, 130.28, 129.48, 129.34, 129.31,
29.27, 128.95, 128.17, 127.19, 126.99, 126.78, 126.44, 125.57,
24.38, 123.91, 122.99, 121.05, 120.99, 120.29, 120.20, 31.62,
1.40, 30.51, 30.37, 29.62, 29.20, 29.09, 28.96, 28.83, 23.93,
3
CH-(CH
a-CH ), 1.80–1.50 (m, 72H), 1.41–1.10 (m, 72H), 1.19 (d, J =
.8 Hz, 36H, Ph-CH-(CH ) ), 0.95–0.85 (m, 45H, Th9-Th0--
3 2 2
) , Th-a9-a0--CH ), 2.46 (t, J = 7.6 Hz, 6H, Th-
2
6
3
2
13
CH ), 0.78 (t, J = 7.6 Hz, 9H, Th-CH ); C NMR (CDCl3):
3
3
+
2.54, 22.38, 14.00, 13.89; MALDI-TOF m/z = 2680 (M + H );
d = 163.86, 145.65, 142.84, 141.88, 140.50, 139.84, 139.79,
Anal. Calcd for C180H174N O S : C 80.56, H 6.61, N 2.09;
4 6 6
1
1
1
1
1
1
2
2
37.50, 137.23, 136.70, 135.77, 134.86, 134.09, 133.93, 133.86,
33.77, 133.74, 132.02, 131.98, 131.96, 131.89, 130.96, 130.46,
30.31, 129.51, 129.38, 129.35, 129.32, 129.30, 128.53, 128.50,
28.48, 128.44, 128.36, 128.21, 127.22, 127.13, 126.90, 126.37,
24.32, 123.96, 123.89, 123.84, 12.01, 121.09, 121.02, 120.36,
20.32, 120.28, 31.58, 31.37, 30.45, 30.39, 30.34, 30.30, 29.53,
9.40, 29.37, 29.23, 29.14, 29.08, 29.04, 28.92, 28.79, 23.89,
Found: C 80.38, H 6.72, N 2.12%.
Tris{4-[8-(2-(2,6-diisopropylphenyl)-1H-benzo[5,10]anthra-
[
2,1,9-def]isoquinoline-1,3(2H)-dione)]-4,39,30,3-0-tetrahexyl-
,29;59,20;50,2--quaterthien-5--yl]-phenyl}amine (7)
2
Following the general procedure, 191 mg (0.15 mmol)
perylenyl–quaterthiophene 6, 31 mg (0.05 mmol) of boronic
ester 3, 12 mg (0.3 mmol) sodium hydroxide and 35 mg
+
2.53, 22.36, 13.98, 13.86; MALDI-TOF m/z = 4673 (M + H );
Anal. Calcd for C300H342N O S : C 77.01, H 7.41, N 1.20;
6 18
4
Found: C 77.22, H 7.54, N 1.31%.
,39-Dihexyl-5-methyl-2,29-bithiophene (11)
(
0.03 mmol) tetrakis(triphenylphosphine)palladium(0) in 15 ml
DME were reacted at 80 uC for 24 hours to give 7 (100 mg,
4%) as a black solid after column chromatography (dichloro-
4
5
1
methane : petrol ether [5 : 1]): mp 192–193 uC; H NMR
To bithiophene 10 (1.24 g, 3 mmol) in THF (6 ml) at 280 uC
was added n-BuLi (1.9 ml, 3 mmol). After stirring at 280 uC
for 15 min methyl trifluoromethanesulfonate (0.54 g, 3.3 mmol)
was added and the solution was allowed to warm up to room
temperature. Next, 0.5 ml of a 1 molar sodium hydroxide
solution was added to deactivate the excessive methyl triflate
before the solvent was completely removed by rotary evapora-
tion. The remaining residue was suspended in 20 ml n-hexane
and the resulting suspension was poured into 100 ml water.
The water phase was extracted with n-hexane (three times
20 ml) and subsequently, the combined organic phases were
washed with water and were dried over sodium sulfate. Next,
the solvent was removed by rotary evaporation and the crude
product was distilled in vacuo to yield methylated thiophene 11
(0.73 g, 70%) as a pale yellow, viscous liquid. Bp 147 uC (1.1 6
(
CDCl
3
): d = 8.66 (d, J = 7.9 Hz, 6H, Pery-1H,6H), 8.51–8.44
(
m, 12H, Pery-2H,5H,7H,12H), 8.00 (d, J = 8.6 Hz, 3H, Pery-
8
H), 7.70 (d, J = 7.8 Hz, 3H, Pery-10H), 7.65 (t, J = 7.9 Hz,
H, Pery-11H), 7.51 (d, J = 8.6 Hz, 6H, TPA-3H,5H), 7.49 (t,
3
J = 7.8, 3H, Ph-4H), 7.34 (d, J = 7.8 Hz, 6H, Ph-3H,5H), 7.17–
7
.10 (m, 12H, TPA-2H,6H,Th-3H,49H), 7.03 (s, 3H, Th-40H),
.01 (s, 3H, Th-4-H), 2.90–2.75 (m, 24H, Ph-CH-(CH
7
3 2
) ,
Th-a9-a--CH ), 2.46 (t, J = 7.5 Hz, 6H, Th-a-CH ), 1.80–1.69
2
2
(
m, 18H, Th-b9-b--CH ), 1.65–1.41 (m, 30H, -CH -), 1.41–1.10
2 2
(
m, 48H, -CH
2
-), 1.20 (d, J = 6.8 Hz, 36H, Ph-CH-(CH
.95–0.85 (m, 27H, Th9-Th--CH ), 0.78 (t, J = 7.6 Hz, 9H,
): d = 163.85, 146.37, 145.65,
3 2
) ),
0
3
1
3
3 3
Th-CH ); C NMR (CDCl
1
1
1
1
1
3
2
41.88, 141.31, 140.53, 139.85, 137.45, 137.18, 135.80, 134.84,
34.15, 133.93, 133.83, 131.93, 130.98, 130.43, 130.28, 130.11,
29.50, 129.34, 129.31, 128.91, 128.50, 128.36, 128.19, 127.21,
27.13, 126.83, 126.38, 125.53, 124.33, 123.95, 123.90, 123.00,
21.07, 121.00, 120.33, 120.24, 31.61, 31.59, 31.38, 30.47,
0.43, 30.41, 30.36, 29.56, 29.43, 29.40, 29.17, 29.06, 28.94,
2
2
1
10 mbar); H NMR (CDCl ): d = 7.11 (d, J = 5.2 Hz, 1H,
3
59-H), 6.90 (d, J = 5.2 Hz, 1H, 49-H), 6.81 (s, 1H, 3-H), 2.72 (t,
J = 7.8 Hz, 2H, a9-H), 2.49 (t, J = 7.7 Hz, 2H, a-H), 2.34 (s, 3H,
T-CH ), 1.65–1.55 (m, 4H, b,b9-H), 1.42–1.28 (m, 12H, -CH -),
3
2
1
0.92–0.85 (m, 6H, -CH3); C NMR (CDCl ): d = 138.82,
3
8.82, 23.91, 22.54, 22.53, 22.37, 14.01, 14.00, 13.98, 13.87;
+
3
MALDI-TOF m/z = 3677 (M + H ); Anal. Calcd for
138.73, 132.70, 131.31, 131.24, 129.82, 127.82, 122.90, 31.72,
C
240
H
258
N
4
O
6
S
12: C 78.34, H 7.07, N 1.52; Found: C 79.58,
31.67, 30.70, 40.41, 29.22, 29.15, 29.09, 28.23, 22.63, 22.61,
+
14.07, 14.06, 12.86; EI m/z (M ) = 348; Anal. Calcd for
H 7.23, N 1.42%.
8
82 | J. Mater. Chem., 2006, 16, 874–884
This journal is ß The Royal Society of Chemistry 2006